• Hsa_circ_0001944, FXR/TLR4, and Ferroptosis

  2026-09-08

  The 2025 Toxics study identifies hsa_circ_0001944 as a regulatory link between FXR/TLR4 signaling, ferroptosis, and nickel oxide nanoparticle-induced collagen formation in LX-2 hepatic stellate cells. Its results position FXR activation and circular RNA modulation as mechanistic tools for studying toxicant-associated fibrotic responses, while also highlighting the need for validation beyond an in vitro model.

• ML365: TASK1 Workflows for Translational Research

  2026-09-07

  ML365 combines nanomolar TASK1 inhibition with orthogonal assay compatibility, supporting ion-channel target validation, neuroinflammation studies, and cardiopulmonary research. This guide translates its pharmacology and a 2024 aged-mouse study into practical workflows, controls, and troubleshooting decisions.

• Prestained Protein Marker: Triple-Color Workflow Guide

  2026-09-07

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides visible reference bands for monitoring SDS-PAGE migration, checking transfer, and supporting protein size verification. It is intended for routine electrophoresis and Western blot workflows, not for absolute protein quantification, exact mass determination, or samples outside the 10-250 kDa range.

• AY 9944 dihydrochloride: DHCR7 Workflow

  2026-09-05

  Build controlled DHCR7 perturbation experiments with AY 9944 dihydrochloride, from 7-dehydrocholesterol profiling to membrane-raft and PBMC assays. The workflow also shows how the compound can inform, but not replace, genetic evidence from dhcr7-edited grass carp challenged with GCRV.

• Annexin V-Cy5/DAPI Apoptosis Kit Guide

  2026-09-04

  The Annexin V-Cy5/DAPI Apoptosis Kit provides a rapid phosphatidylserine binding assay for paired assessment of apoptosis-associated PS exposure and DAPI uptake. The K2255 workflow supports apoptosis and necrosis differentiation by fluorescence microscopy or flow cytometry within the product-reported 10–20 minute staining interval.

• Sulfo-NHS-Biotin for CADASIL Surface Proteomics

  2026-09-04

  Sulfo-NHS-Biotin converts the NOTCH3 R545C CADASIL model into a practical platform for profiling vascular and neuronal cell-surface changes. This guide combines amine-selective chemistry with surface-proteome capture, affinity enrichment, and troubleshooting strategies for reproducible mechanistic studies.

• Anlotinib Hydrochloride: Assay Logic for Angiogenesis

  2026-09-03

  Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor that reveals how VEGFR2, PDGFRβ, FGFR1, and ERK signaling jointly control angiogenesis. This guide translates the core study into a decision-focused framework for endothelial assays, mechanistic validation, and cancer research.

• GSK 2837808A: LDHA Inhibition Workflow

  2026-09-03

  GSK 2837808A provides a focused way to test LDHA-dependent lactate production, glucose consumption, and metabolic signaling without treating glycolysis as a single undifferentiated process. This workflow connects validated hepatocellular carcinoma applications with hypothesis-driven studies of the NAT1–ENO1–lactate–PD-L1 axis in colorectal cancer.

• ETV5, EZH2, and Hepatocellular Carcinoma Progression

  2026-09-02

  The reference study integrates TCGA and GTEx data with experimental validation to identify ETV5 as a prognostic, epigenetically associated oncogenic factor across cancers, with particularly important effects in hepatocellular carcinoma. Its finding that ETV5 promotes proliferation and reduces sensitivity to the EZH2-targeting compound GSK126 connects transcription-factor activity with therapeutic response and provides a testable framework for cancer epigenetics research.

• Fenipentol: From Choleresis to Translational Insight

  2026-09-02

  Fenipentol, also called 1-Phenyl-1-pentanol, connects historical secretory physiology with modern ESR1-focused assay design. This thought-leadership guide explains how to validate its mechanism, manage isomer confusion, and position the compound for gastrointestinal and hepatobiliary translation.

• BCL-2 Targeting Across Heterogeneous CRPC

  2026-09-01

  This study integrates single-cell imaging, mechanistic experiments, therapeutic models, and a Phase Ib trial to establish BCL-2 as a shared vulnerability across heterogeneous castration-resistant prostate cancer. Its findings show that androgen receptor pathway inhibition can increase BCL-2-positive tumor-cell populations, supporting combination strategies that address both AR-positive and AR-low disease states.

• CHIR-99021: GSK-3 Strategy for Stem Cell Translation

  2026-09-01

  CHIR-99021 (CT99021) is more than a pathway activator: it is a reversible tool for testing how GSK-3, β-catenin stability, receptor context, and cell state interact. This thought-leadership guide connects mechanistic findings on semaphorin receptor-mediated Wnt repression with practical experimental design, translational stem cell workflows, and a more rigorous framework for interpreting pluripotency and differentiation data.

• Lanabecestat (AZD3293) for BACE1 Assays

  2026-08-31

  Lanabecestat (AZD3293) enables controlled BACE1 enzyme inhibition in neuronal models, pairing amyloid-beta production inhibition with a parallel readout of synaptic function. This workflow uses moderate exposure windows to distinguish useful amyloidogenic pathway modulation from excessive pathway suppression.

• Camptothecin: Topoisomerase I Inhibitor Guide

  2026-08-31

  Camptothecin is a selective topoisomerase I inhibitor that stabilizes DNA cleavage complexes and produces measurable DNA damage responses. Its defined chemistry, DMSO handling profile, and reported activity in cancer models make it useful for mechanistic cancer research, while assay context and cellular adaptation remain important limitations.

• GW4064 Workflows for FXR Metabolic Research

  2026-08-30

  GW4064 is a nanomolar non-steroidal FXR agonist for connecting receptor activation with bile acid transport, lipid regulation, and cholestatic injury phenotypes. This practical guide shows how to design concentration-response assays, efflux studies, and mechanism-focused controls while managing solubility and light-stability limitations.

8247 records 1/550 page Next 12345 下5页 Last page